44
Participants
Start Date
April 30, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
telbivudine
Novartis Investigative Site (705-035), Daegu
Novartis Investigative Site , (420-717), Gyeonggi-do
Novartis Investigative Site , (405-760), Incheon
Novartis Investigative Site , (136-705), Seoul
Novartis Investigative Site , (150-590), Seoul
Novartis Investigative Site, Seoul
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY